Agape ATP Corporation (NASDAQ:ATPC) Short Interest Update

Agape ATP Corporation (NASDAQ:ATPCGet Free Report) saw a large decrease in short interest in the month of January. As of January 15th, there was short interest totaling 1,263,530 shares, a decrease of 16.9% from the December 31st total of 1,520,541 shares. Based on an average daily volume of 59,987,939 shares, the days-to-cover ratio is currently 0.0 days. Approximately 2.6% of the company’s shares are sold short. Approximately 2.6% of the company’s shares are sold short. Based on an average daily volume of 59,987,939 shares, the days-to-cover ratio is currently 0.0 days.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Agape ATP in a report on Wednesday, January 21st. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Agape ATP presently has a consensus rating of “Sell”.

View Our Latest Analysis on ATPC

Agape ATP Price Performance

Shares of NASDAQ:ATPC traded up $0.01 during trading hours on Wednesday, hitting $0.09. The company’s stock had a trading volume of 20,436,206 shares, compared to its average volume of 32,202,029. The firm’s fifty day moving average price is $0.34 and its 200 day moving average price is $0.95. Agape ATP has a 52 week low of $0.05 and a 52 week high of $2.57. The company has a market capitalization of $4.28 million, a price-to-earnings ratio of -0.29 and a beta of -0.35.

Institutional Investors Weigh In On Agape ATP

An institutional investor recently raised its position in Agape ATP stock. Citadel Advisors LLC boosted its stake in shares of Agape ATP Corporation (NASDAQ:ATPCFree Report) by 95.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 65,130 shares of the company’s stock after purchasing an additional 31,849 shares during the quarter. Citadel Advisors LLC owned about 0.13% of Agape ATP worth $82,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 0.01% of the stock is currently owned by institutional investors.

About Agape ATP

(Get Free Report)

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.

Further Reading

Receive News & Ratings for Agape ATP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agape ATP and related companies with MarketBeat.com's FREE daily email newsletter.